In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...